Intersect ENT Inc (XENT)

์ƒ์žฅ๊ฑฐ๋ž˜์†Œ: NASDAQ | ์‚ฐ์—…: ์˜๋ฃŒ์„œ๋น„์Šค

๊ธฐ์—…๊ฐœ์š”

์ถœ์ฒ˜: ์•ผํ›„ ํŒŒ์ด๋‚ธ์Šค
์•ฝ๋ฌผ ์ „๋‹ฌ ํšŒ์‚ฌ ์ธ Intersect ENT, Inc.๋Š” ๋ฏธ๊ตญ์—์„œ ๊ท€, ์ฝ” ๋ฐ ์ธํ›„ ์ƒํƒœ์˜ ํ™˜์ž ์น˜๋ฃŒ๋ฅผ์œ„ํ•œ ์ œํ’ˆ์„ ์—ฐ๊ตฌ ๋ฐ ๊ฐœ๋ฐœํ•ฉ๋‹ˆ๋‹ค. ๊ทธ๊ฒƒ์€ ๋งŒ์„ฑ ๋ถ€๋น„๋™์—ผ์„ ์น˜๋ฃŒํ•˜๊ธฐ ์œ„ํ•ด ๋ถ€๋น„๋™ ์ˆ˜์ˆ ์„๋ฐ›๋Š” ํ™˜์ž์—๊ฒŒ PROPEL ๋ฐ PROPEL ๋ฏธ๋‹ˆ ์•ฝ๋ฌผ ๋ฐฉ์ถœ ์ž„ํ”Œ๋ž€ํŠธ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๊ทธ๋ฆฌ๊ณ  ๋ถ€๋น„๋™์˜ ์ •๋ฉด ๋ฐ ์ƒ์•…๋™ ๊ฐœ๊ตฌ๋ถ€์— ์Šคํ…Œ๋กœ์ด๋“œ๋ฅผ ๋ฐฉ์ถœํ•˜๋Š” PROPEL Contour. ์ด ํšŒ์‚ฌ๋Š” ๋˜ํ•œ ์˜์‚ฌ ์‚ฌ๋ฌด์‹ค ํ™˜๊ฒฝ์—์„œ ํ™˜์ž ์น˜๋ฃŒ๋ฅผ์œ„ํ•œ ๋‚ด๊ณผ ์  ์งˆํ™˜์„์œ„ํ•œ ์Šคํ…Œ๋กœ์ด๋“œ ๋ฐฉ์ถœ ์ด์‹ ์ธ SINUVA๋ฅผ ๊ฐœ๋ฐœ ์ค‘์ด๋‹ค. ์ด ํšŒ์‚ฌ๋Š” ์ด์ „์— Sinexus, Inc.๋กœ ์•Œ๋ ค์กŒ์œผ๋ฉฐ 2009 ๋…„ 11 ์›” Intersect ENT, Inc.๋กœ ์ด๋ฆ„์„ ๋ฐ” ๊พธ์—ˆ์Šต๋‹ˆ๋‹ค. Intersect ENT, Inc.๋Š” 2003 ๋…„์— ์„ค๋ฆฝ๋˜์—ˆ์œผ๋ฉฐ ์บ˜๋ฆฌํฌ๋‹ˆ์•„ ์ฃผ ๋ฉ˜๋กœ ํŒŒํฌ์— ๋ณธ์‚ฌ๊ฐ€ ์žˆ์Šต๋‹ˆ๋‹ค.

A. ์ฃผ์š”์ง€ํ‘œ

ํŽ€๋”๋ฉ˜ํƒˆ

์ฃผ์š”์ง€ํ‘œ(TTM)
2017/Q3 2018/Q3
PER -50.58 -63.49
PBR 7.98 14.57
PCR -102.32 -205.16
PSR 10.02 10.60
์ฃผ๋‹น๋ฐฐ๋‹น๊ธˆ(๋‹ฌ๋Ÿฌ) 0.00 0.00
๋ฐฐ๋‹น์ˆ˜์ต๋ฅ (%) 0.00 0.00

Wonderful company at Fair price

โ€ป์•„๋ž˜ ์žฌ๋ฌด๋น„์œจ๊ณผ ์‚ฐ์—…ํ‰๊ท  ๊ฐ’์€ 2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€ TTM(12๊ฐœ์›”) ๊ฐ’์ž…๋‹ˆ๋‹ค.
  • Wonderful company
์ˆ˜์ต์„ฑ & ์„ฑ์žฅ์„ฑ (2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€)
๋™์ข…์‚ฐ์—…ํ‰๊ท 
ROE(%) -22.95 0.56
ROIC(%) -25.07 -2.51
EPS์„ฑ์žฅ๋ฅ (%) 24.06 3.96
์•ˆ์ •์„ฑ (2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€)
๋™์ข…์‚ฐ์—…ํ‰๊ท 
๋ถ€์ฑ„๋น„์œจ(%) 15.66 71.67
์ฐจ์ž…๊ธˆ์˜์กด๋น„์œจ(%) 0.00 21.10
์ด์ž๋ณด์ƒ๋น„์œจ NA -0.79
  • Fair Price
์ ์ •๊ฐ€๊ฒฉ์ง€ํ‘œ (2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€)
๋™์ข…์‚ฐ์—…ํ‰๊ท 
PER -63.49 -0.27
PEG 587.91 4.06
EV/EBIT 352.41 4.76
EV/EBITDA -2.64 -0.85

B. ์žฌ๋ฌด์ œํ‘œ

์žฌ๋ฌด์ƒํƒœํ‘œ

(๋‹จ์œ„: 1000๋‹ฌ๋Ÿฌ)
2013 2014 2015 2016 2017
์ด์ž์‚ฐ 21,035 62,953 144,635 129,777 135,575
ํ˜„๊ธˆ๋ฐํ˜„๊ธˆ์„ฑ์ž์‚ฐ 12,294 13,403 34,809 9,859 19,837
๋งค์ถœ์ฑ„๊ถŒ 4,200 8,337 11,468 14,421 16,589
์žฌ๊ณ ์ž์‚ฐ 2,197 2,547 3,949 5,613 8,474
๋‹จ๊ธฐ๊ธˆ์œตํˆฌ์ž์ž์‚ฐ NA 35,040 89,491 94,086 82,483
๊ธฐํƒ€์œ ๋™์ž์‚ฐ 511 951 1,495 1,313 2,908
์ด์œ ๋™์ž์‚ฐ 19,202 60,278 141,212 125,292 130,291
์žฅ๊ธฐ๊ธˆ์œตํˆฌ์ž์ž์‚ฐ NA NA NA NA NA
์ˆœ์œ ํ˜•์ž์‚ฐ 1,707 1,474 3,183 4,127 4,848
๋ฌดํ˜•์ž์‚ฐ NA NA NA NA NA
์˜์—…๊ถŒ NA NA NA NA NA
์ด๋น„์œ ๋™์ž์‚ฐ 126 1,201 240 358 436
์ด๋ถ€์ฑ„ 6,892 9,141 14,404 15,380 18,356
๋งค์ž…์ฑ„๋ฌด 1,451 2,128 1,908 3,267 3,400
๋‹จ๊ธฐ์ฐจ์ž…๊ธˆ 696 NA NA NA NA
๋ฏธ์ง€๊ธ‰๊ธˆ NA NA NA NA NA
๊ธฐํƒ€์œ ๋™๋ถ€์ฑ„ 2,955 5,085 9,588 10,152 13,152
์ด์œ ๋™๋ถ€์ฑ„ 6,084 8,111 13,070 14,364 17,677
์žฅ๊ธฐ์ฐจ์ž…๊ธˆ 756 NA NA NA NA
๊ธฐํƒ€๋น„์œ ๋™๋ถ€์ฑ„ 52 1,030 1,334 1,016 679
์ด์ž๋ณธ -76,617 53,812 130,231 114,397 117,219
์ด์šฐ์„ ์ฃผ์ž๋ณธ๊ธˆ 0 0 0 0 0
์ด๋ณดํ†ต์ฃผ์ž๋ณธ๊ธˆ -76,617 53,812 130,231 114,397 117,219
๋ณดํ†ต์ฃผ์ž๋ณธ๊ธˆ 1,861 150,433 253,478 262,911 282,151
์ด์ต์ž‰์—ฌ๊ธˆ -78,259 -96,621 -123,255 -148,477 -164,840
์ž์‚ฌ์ฃผ๋งค์ž… NA NA NA NA NA
๊ธฐํƒ€ํฌ๊ด„์†์ต๋ˆ„๊ณ„์•ก NA NA 8 -37 -92
๊ธฐํƒ€์ž๋ณธ -219 NA NA NA NA
๋น„์ง€๋ฐฐ์ง€๋ถ„ NA NA NA NA NA

์†์ต๊ณ„์‚ฐ์„œ

(๋‹จ์œ„: 1000๋‹ฌ๋Ÿฌ)
2012 2013 2014 2015 2016 2017
์ด๋งค์ถœ 5,863 17,931 38,587 61,593 78,708 96,301
๋งค์ถœ์›๊ฐ€ 3,837 8,150 10,223 12,288 13,003 15,499
๋งค์ถœ์ด์ด์ต 2,026 9,781 28,364 49,305 65,705 80,802
๊ฐ๊ฐ€์ƒ๊ฐ๋น„ NA NA NA NA NA NA
ํŒ๋งค๊ด€๋ฆฌ๋น„ 18,511 27,747 46,442 76,245 91,816 98,405
์˜์—…์ด์ต -16,485 -17,966 -18,078 -26,940 -26,111 -17,603
์ด์ž๋น„์šฉ 36 403 NA NA NA NA
๊ธฐํƒ€์ˆ˜์ต 120 -403 NA NA NA NA
๋ฒ•์ธ์„ธ๋น„์šฉ์ฐจ๊ฐ์ „์ด์ต -16,365 -18,369 -18,078 -26,940 -26,111 -17,603
๋ฒ•์ธ์„ธ๋น„์šฉ NA NA NA NA NA NA
๋‹น๊ธฐ์ˆœ์ด์ต -16,365 -18,369 -18,362 -26,634 -25,222 -16,363
๊ณ„์†์˜์—…์ด์ต -16,365 -18,369 -18,362 -26,634 -25,222 -16,363
์ค‘๋‹จ์‚ฐ์—…์ด์ต NA NA NA NA NA NA
๋น„์ง€๋ฐฐ๋‹น๊ธฐ์ˆœ์ด์ต NA NA NA NA NA NA

ํ˜„๊ธˆํ๋ฆ„ํ‘œ

(๋‹จ์œ„: 1000๋‹ฌ๋Ÿฌ)
2012 2013 2014 2015 2016 2017
์˜์—…ํ™œ๋™ํ˜„๊ธˆํ๋ฆ„ -16,148 -19,101 -17,954 -20,087 -20,059 -8,041
๋‹น๊ธฐ์ˆœ์ด์ต -16,365 -18,369 -18,362 -26,634 -25,222 -16,363
๋น„ํ˜„๊ธˆ์กฐ์ • 173 854 1,848 4,884 7,467 9,820
๊ฐ๊ฐ€์ƒ๊ฐ 434 505 747 1,508 1,314 1,483
์šด์ „์ž๋ณธ์ฆ๊ฐ -390 -2,091 -2,187 155 -3,618 -2,981
์ด์ž์ง€๊ธ‰ NA 93 53 NA NA NA
์ด์ž์ˆ˜์ทจ NA NA NA NA NA NA
๋ฒ•์ธ์„ธ๋‚ฉ๋ถ€์•ก NA NA NA NA NA NA
๋Œ€์†์ถฉ๋‹น๊ธˆ NA NA NA NA NA NA
ํˆฌ์žํ™œ๋™ํ˜„๊ธˆํ๋ฆ„ 5,956 -467 -35,519 -56,669 -6,857 9,248
์œ ํ˜•์ž์‚ฐ์ฒ˜๋ถ„ NA NA NA NA NA NA
ํˆฌ์ž์ƒํ’ˆ์ฒ˜๋ถ„ 8,622 NA NA 129,527 149,131 128,151
์œ ํ˜•์ž์‚ฐ์ทจ๋“ -1,413 -467 -367 -1,524 -2,069 -2,281
ํˆฌ์ž์ƒํ’ˆ์ทจ๋“ -1,324 NA -35,152 -184,672 -153,919 -116,622
๊ธฐํƒ€ํˆฌ์žํ™œ๋™ 71 0 0 0 0 0
์žฌ๋ฌดํ™œ๋™ํ˜„๊ธˆํ๋ฆ„ 2,302 29,802 54,582 98,162 1,966 8,771
์ฃผ์‹๋ฐœํ–‰ 89 122 232 1,770 1,966 8,771
์‚ฌ์ฑ„๋ฐœํ–‰ NA 106 55,802 96,392 NA NA
์ฃผ์‹์ทจ๋“ NA NA NA NA NA NA
๋ถ€์ฑ„์ƒํ™˜ NA -654 -1,452 NA NA NA
๋ฐฐ๋‹น๊ธ‰์ง€๊ธ‰ NA NA NA NA NA NA
๊ธฐํƒ€์žฌ๋ฌดํ™œ๋™ 2,213 82 NA NA NA NA
์™ธํ™”ํ™˜์ƒ์œผ๋กœ์ธํ•œํ˜„๊ธˆ์˜๋ณ€๋™ NA NA NA NA NA NA
ํ˜„๊ธˆ์˜์ฆ๊ฐ -7,890 10,234 1,109 21,406 -24,950 9,978

C. ๋‚ด๋ถ€/๊ธฐ๊ด€ํˆฌ์ž์ž

๋‚ด๋ถ€์ž ๊ฑฐ๋ž˜๋‚ด์—ญ

๊ธฐ๊ด€ํˆฌ์ž์ž

D. ๋‰ด์Šค

โ€ป2018๋…„ 12์›” 1์ผ ๊ธฐ์ค€ ์ตœ๊ทผ 15๊ฐœ์˜ ๋‰ด์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.
๋‚ ์งœ ์ œ๋ชฉ summary url
2018-11-20 ํŽธ์ง‘ ๋œ XENT ์‹ค์  ์ปจํผ๋Ÿฐ์Šค ์ „ํ™” ๋˜๋Š” ํ”„๋ฆฌ์   ํ…Œ์ด์…˜ 5-Nov-18 1:00 GMT Q3 2018 Intersect Ent Inc ์ˆ˜์ž… ํ†ตํ™” https://finance.yahoo.com/news/edited-transcript-xent-earnings-conference-201008134.html?.tsrc=rss
2018-11-15 Intersect ENT, ์ •๋ฉด ๋ถ€๋น„๋™ ์ˆ˜์ˆ  ํ›„ ํ™˜์ž์—๊ฒŒ ์Šคํ…Œ๋กœ์ด๋“œ ๋ฐฉ์ถœ ์ด์‹์ˆ ์— ๋Œ€ํ•œ ๊ณต๋™ ๋ถ„์„ ๋ฐœํ‘œ ์ฝ”, ์ธํ›„ ์กฐ๊ฑด์„ ๊ฐ€์ง„ ํ™˜์ž๋“ค์„ ๋Œ๋ณด๋Š” ๋ฐ ์ „๋…ํ•˜๋Š” Interters, Inc. (XENT)๋Š” ์˜ค๋Š˜ American Rhinologic Society์˜ ๊ณต์‹ ์ €๋„ ์ธ Allergy & Rhinology์˜ ๊ตญ์ œ ํฌ๋Ÿผ์— ๊ณต๋™ ๋ถ„์„ ๊ฒฐ๊ณผ๋ฅผ ๋ฐœํ‘œํ–ˆ๋‹ค. ์˜ PROPELยฎ Contour ๋ฐ PROPELยฎ Mini ์Šคํ…Œ๋กœ์ด๋“œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ์ •๋งฅ๋™ ์ˆ˜์ˆ ์˜ ๊ฐœ์„  ๋œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์—ฌ์ฃผ๋Š” ๋ถ€๋น„๋™ ์ž„ํ”Œ๋ž€ํŠธ๋ฅผ ์ถœ์‹œํ–ˆ์Šต๋‹ˆ๋‹ค. ๋ถ€๋น„๋™ ์ˆ˜์ˆ  ํ›„ ํ™˜์ž๋ฅผ ๋ฌด์ž‘์œ„๋กœ ์ •๋ณตํ•˜์—ฌ ํ•œ์ชฝ ์ •๋ฉด ๋ถ€๋น„๋™ ๊ฐœ๊ตฌ๋ถ€์— ์ด์‹ํŽธ์„ ๋ฐ›์•˜๋‹ค. ์ด ํ’€ ๋ถ„์„ ๊ฒฐ๊ณผ PROPEL ์ „๋ฆฝ์„  ์Šคํ…Œ๋กœ์ด๋“œ ๋ฐฉ์ถœ ์ž„ํ”Œ๋ž€ํŠธ๋Š” ์ˆ˜์ˆ  ๋‹จ๋…์— ๋น„ํ•ด ์ „๋‘๋ถ€ ์ˆ˜์ˆ ์˜ ๋‚ด์‹œ๊ฒฝ ๊ฒฐ๊ณผ๋ฅผ ์œ ์˜ํ•˜๊ฒŒ ํ–ฅ์ƒ์‹œ์ผฐ๋‹ค. https://finance.yahoo.com/news/intersect-ent-announces-publication-pooled-210600578.html?.tsrc=rss
2018-11-07 ENT, Piper Jaffray์—์„œ ์—ฐ๋ก€ ์˜๋ฃŒ ์ปจํผ๋Ÿฐ์Šค ๊ฐœ์ตœ Intersect ENT, Inc. (XENT)๋Š” ์˜ค๋Š˜ ๋‰ด์š•์‹œ์˜ Lotte New York Palace์—์„œ 11 ์›” 28 ์ผ 30 ํšŒ Piper Jaffray Health Care Conference์— ์ฐธ๊ฐ€ํ•  ์˜ˆ์ •์ด๋ฉฐ ๋™๋ถ€ ์‹œ๊ฐ„์œผ๋กœ 10:30์— ์„ธ์…˜์— ์ฐธ์„ํ•  ์˜ˆ์ •์ด๋ผ๊ณ  ๋ฐœํ‘œํ–ˆ์Šต๋‹ˆ๋‹ค. https://finance.yahoo.com/news/intersect-ent-present-piper-jaffray-210500357.html?.tsrc=rss
2018-11-06 ๋ชจ๋‘ VCEL๊ณผ ํ•จ๊ป˜, MOR์„ ์ง€ํ‚ฌ ์‹œ๊ฐ„, MYL์€ ๋†€๋ผ์›€์„ ๋•๋‹ˆ๋‹ค. ๋ชจ๋‘ VCEL๊ณผ ํ•จ๊ป˜, MOR์„ ์ง€ํ‚ฌ ์‹œ๊ฐ„, MYL์€ ๋†€๋ผ์›€์„ ๋•๋‹ˆ๋‹ค. http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FDNYHWE-rUg/alls-well-with-vcel-time-to-keep-mor-in-mind-myl-pulls-off-surprise-20181106-01653
2018-11-05 Intersect ENT (XENT) Q3 2018 ์ˆ˜์ž… ์ปจํผ๋Ÿฐ์Šค ์ฝœ ๋Œ€๋ณธ XENT ์ˆ˜์ต์€ 2018 ๋…„ 9 ์›” 30 ์ผ ์ข…๋ฃŒ ๊ธฐ๊ฐ„์„ ์š”๊ตฌํ•ฉ๋‹ˆ๋‹ค. https://finance.yahoo.com/news/intersect-ent-xent-q3-2018-205140680.html?.tsrc=rss
2018-11-05 Intersect ENT (XENT), Q3 ์†์‹ค, ๋งค์ถœ ์ถ”์ •์น˜ ์ƒํ–ฅ ์กฐ์ • Intersect ENT (XENT)๋Š” 2018 ๋…„ 9 ์›” ์ข…๋ฃŒ ๋ถ„๊ธฐ์— ๊ฐ๊ฐ 3.85 %์™€ 2.26 %์˜ ์ˆ˜์ต๊ณผ ๋งค์ถœ ๋†€๋ผ์›€์„์ฃผ์—ˆ์Šต๋‹ˆ๋‹ค.์ด ์ˆ˜์น˜๋Š” ์ฃผ์‹์— ๋Œ€ํ•œ ์•ž์œผ๋กœ์˜ ์˜ˆ์ธก์— ๋Œ€ํ•œ ๋‹จ์„œ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๊นŒ? https://finance.yahoo.com/news/intersect-ent-xent-reports-q3-131501427.html?.tsrc=rss
2018-11-05 Intersect ENT : 3 ๋ถ„๊ธฐ ์‹ค์  ์Šค๋ƒ… ์ƒท ์บ˜๋ฆฌํฌ๋‹ˆ์•„ ์ฃผ ๋ฉ˜๋กœ ํŒŒํฌ (Menlo Park)์— ๋”ฐ๋ฅด๋ฉด ์ฃผ๋‹น 25 ์„ผํŠธ์˜ ์†์‹ค์ด ๋ฐœ์ƒํ–ˆ๋‹ค๊ณ ํ•œ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ๋Š” ์›”์ŠคํŠธ๋ฆฌํŠธ์˜ ๊ธฐ๋Œ€๋ฅผ ๋›ฐ์–ด ๋„˜์—ˆ๋‹ค. Zacks Investment Research๊ฐ€ ์กฐ์‚ฌํ•œ 6 ๋ช…์˜ ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ท  ์ถ”์ •์น˜ โ€ฆ https://finance.yahoo.com/news/intersect-ent-3q-earnings-snapshot-120937293.html?.tsrc=rss
2018-11-05 2018 ๋…„ 3 ๋ถ„๊ธฐ ๊ฒฐ๊ณผ ENT ๋ณด๊ณ ์„œ ๊ต์ฐจ ๊ท€, ์ฝ”, ๋ชฉ ์กฐ๊ฑด์˜ ํ™˜์ž๋“ค์˜ ์‚ถ์˜ ์งˆ ํ–ฅ์ƒ์— ์ „๋…ํ•˜๋Š” ํšŒ์‚ฌ ์ธ Intersect ENT, Inc.๋Š” 2018 ๋…„ 9 ์›” 30 ์ผ ๋๋‚œ 3 ๋ถ„๊ธฐ ์žฌ๋ฌด ๊ฒฐ๊ณผ๋ฅผ ์˜ค๋Š˜ ๋ฐœํ‘œํ–ˆ์Šต๋‹ˆ๋‹ค. https://finance.yahoo.com/news/intersect-ent-reports-third-quarter-120000138.html?.tsrc=rss
2018-10-29 Intersect ENT (XENT) Q3 ์ˆ˜์ต Preview : ์ถœ์‹œ๋ฅผ ์•ž๋‘๊ณ  ๋Œ€๋น„ํ•ด์•ผ ํ•  ์‚ฌํ•ญ Intersect ENT (XENT)๋Š” ๋‹ค๊ฐ€์˜ค๋Š” ๋ณด๊ณ ์„œ์—์„œ ๋‘ ๊ฐ€์ง€ ์ค‘์š”ํ•œ ์š”์†Œ์˜ ์ ์ ˆํ•œ ์กฐํ•ฉ์„ ๋‹ฌ์„ฑํ•˜์ง€ ๋ชปํ•ฉ๋‹ˆ๋‹ค. ์ฃผ์š” ๊ธฐ๋Œ€์น˜์— ๋Œ€๋น„ํ•˜์‹ญ์‹œ์˜ค. https://finance.yahoo.com/news/intersect-ent-xent-q3-earnings-143102542.html?.tsrc=rss
2018-10-29 Intersect ENT, Executive Team ์ž„๋ช… ๋ฐœํ‘œ Christine Kowalski๋Š” ์ตœ๊ณ  ์šด์˜ ์ฑ…์ž„์ž (Chief Operations Officer)๋กœ ํ•ฉ๋ฅ˜ํ•ฉ๋‹ˆ๋‹ค. Susan Stimson, ์ตœ๊ณ  ์ „๋žต ์ฑ…์ž„์ž (Chief Strategy Officer) ์„ ์ • https://finance.yahoo.com/news/intersect-ent-announces-executive-team-130000012.html?.tsrc=rss
2018-10-25 Ampio Pharmaceuticals, Virtusa, Umpqua, Hamilton Lane์—์„œ 2018 ๋…„ ์˜ํ–ฅ ์š”์ธ, ์ฃผ์š” ์ง€ํ‘œ ๋ฐ ๊ธฐํšŒ ENT, Akari Therapeutics, Ampio Pharmaceuticals, Hamilton Lane์˜ ๊ฒฝ์ œ ์„ฑ์žฅ์„ ๊ฐ•์กฐํ•˜๋Š” ์ƒˆ๋กœ์šด ์—ฐ๊ตฌ ๋‰ด์š•, 2018 ๋…„ 10 ์›” 25 ์ผ - ์˜ค๋Š˜ ์•„์นจ ์ผ์ฐ ๋ฐœํ‘œ ๋œ ์ƒˆ๋กœ์šด ๋…๋ฆฝ์  ์ธ ์—ฐ๊ตฌ ๋ณด๊ณ ์„œ์—์„œ ๋งˆ์ผ“ ์†Œ์Šค ๋ฆฌ์„œ์น˜ (Market Source Research)๋Š” ๋ชจ๋“  ํ˜„์žฌ ํˆฌ์ž์ž๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์ตœ์‹  ํ•ต์‹ฌ ๊ฒฐ๊ณผ๋ฅผ ๋ฐœํ‘œํ–ˆ์Šต๋‹ˆ๋‹ค. https://finance.yahoo.com/news/factors-influence-2018-key-indicators-125500729.html?.tsrc=rss
2018-10-17 ENT, 2018 ๋…„ 3 ๋ถ„๊ธฐ ์žฌ๋ฌด ์‹ค์  ๋ฐœํ‘œ ๊ท€, ์ฝ”, ๋ชฉ ์กฐ๊ฑด์˜ ํ™˜์ž๋“ค์˜ ์‚ถ์˜ ์งˆ์„ ๊ฐœ์„ ํ•˜๊ณ ์žํ•˜๋Š” ํšŒ์‚ฌ ์ธ Intersect ENT, Inc. (XENT)๋Š” ์˜ค๋Š˜ 2018 ๋…„ 11 ์›” 5 ์ผ์— 3 ๋ถ„๊ธฐ ์žฌ๋ฌด ๊ฒฐ๊ณผ๋ฅผ ๋ฐœํ‘œ ํ•  ๊ฒƒ์ด๋ผ๊ณ  ๋ฐœํ‘œํ–ˆ์Šต๋‹ˆ๋‹ค. ๋™๋ถ€ ํ‘œ์ค€์‹œ ์˜ค์ „ 7์‹œ์— ์„๋ฐฉ๋˜๋ฉฐ ๊ด€๋ฆฌ๋Š” ๋™๋ถ€ ํ‘œ์ค€์‹œ ์˜ค์ „ 8์‹œ์— ์ „ํ™” ํšŒ์˜๋ฅผ ์ฃผ์ตœํ•ฉ๋‹ˆ๋‹ค. ์ธํ„ฐ๋„ท์„ ํ†ตํ•ด ์ „ํ™” ํšŒ์˜์— ์•ก์„ธ์Šคํ•˜๋ ค๋ฉด ํšŒ์‚ฌ ์›น ์‚ฌ์ดํŠธ www.intersectENT.com์—์„œ โ€œInvestor Relationsโ€ํŽ˜์ด์ง€๋กœ ์ด๋™ํ•˜์‹ญ์‹œ์˜ค. https://finance.yahoo.com/news/intersect-ent-report-third-quarter-200500334.html?.tsrc=rss
2018-10-02 ์ฃผ๋ชฉํ• ๋งŒํ•œ ํ™”์š”์ผ ์˜ต์…˜ ํ™œ๋™ : AYI, PAYX, XENT Russell 3000 ์ง€์ˆ˜์˜ ๊ธฐ๋ณธ ๊ตฌ์„ฑ ์š”์†Œ ์ค‘ ์˜ค๋Š˜ ์šฐ๋ฆฌ๋Š” ์ฃผ๋ชฉํ• ๋งŒํ•œ ์˜ต์…˜ ๊ฑฐ๋ž˜๋Ÿ‰์„ Acuity Brands Inc์—์„œ ๋ณด์•˜์Šต๋‹ˆ๋‹ค. Symbol AYI ์ด 3 ๊ฑด์˜ 824 ๊ณ„์•ฝ์ด ์ง€๊ธˆ๊นŒ์ง€ ์•ฝ 382 400 ๊ฑด์˜ ๊ธฐ๋ณธ ์ฃผ์‹์„ ๋Œ€๋ณ€ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ ์ด๋Š” ์•ฝ 60 ๊ฑด์˜ AYI s http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/muvUw9HMmNg/noteworthy-tuesday-option-activity-ayi-payx-xent-cm1031196

E. ๊ธฐํƒ€์žฌ๋ฌด๋น„์œจ

โ€ป์•„๋ž˜ ์žฌ๋ฌด๋น„์œจ์€ 2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€ ๊ฐ’์ž…๋‹ˆ๋‹ค.
์ˆ˜์ต์„ฑ&์„ฑ์žฅ์„ฑ
ROA 0.08
๋งค์ถœ์„ฑ์žฅ๋ฅ  0.16
์„ธํ›„์ˆœ์˜์—…์ด์ต์„ฑ์žฅ๋ฅ  -0.19
์ž‰์—ฌํ˜„๊ธˆํ๋ฆ„์„ฑ์žฅ๋ฅ  -0.20
๋‹น๊ธฐ์ˆœ์ด์ต์„ฑ์žฅ๋ฅ  -0.17
์•ˆ์ •์„ฑ
Debt_to_Nopat 6.32
Altmanzscore -1.72
์žฌ๋ฌด๋ ˆ๋ฒ„๋ฆฌ์ง€๋น„์œจ -1.83
์œ ๋™๋น„์œจ 0.34
ํšจ์œจ์„ฑ
์ด์ž์‚ฐํšŒ์ „์œจ 0.51
ํˆฌํ•˜์ž๋ณธํšŒ์ „์œจ 0.92
๋งค์ถœ์ฑ„๊ถŒํšŒ์ „์œจ 9.87
๋งค์ž…์ฑ„๋ฌดํšŒ์ „์œจ 3.80
์žฌ๊ณ ์ž์‚ฐํšŒ์ „์œจ 12.21

F. ์žฌ๋ฌด๋น„์œจ์„ค๋ช